PATH | VRL
Menu

Find resources

Total results with these characteristics: 207

Disease: Meningococcus

Page 2 of 11
Clones of Neisseria meningitidis Strains in Mali

This article, published in Médecine et Maladies Infectieuses, provides an overview of a cross-sectional, descriptive study to identify strains of Neisseria meningitidis isolated from 2005 to 2007 in Mali. Neisseria meningitidis appeared in 144 …

Author: Guindo I, Coulibaly A, Dao S, et al.

Publication date: 2010

Conducting Vaccine Clinical Trials in Sub-Saharan Africa: Operational Challenges and Lessons Learned From the Meningitis Vaccine Project

The Meningitis Vaccine Project (MVP) was established with the goal of developing, testing, licensing, and introducing an affordable group A meningococcal conjugate vaccine for Africa. The authors of this article, published in Vaccine, describe the …

Author: Marchetti E, Mazarin-Diop V, Chaumont J, et al.

Publication date: 2012

Conjugate Vaccine Introduction in the African Meningitis Belt: Meeting Surveillance Objectives

This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …

Author: Mueller JE

Publication date: 2013

Conjugate Vaccines

This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …

Author: Lockhart S

Publication date: 2003

Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition

These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …

Author: World Health Organization

Publication date: 1998

The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …

Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC

Publication date: 2013

Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States

This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …

Author: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team

Publication date: 2005

Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

Author: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A

Publication date: 2011

Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso

This article, published in Clinical Infectious Diseases, discusses an anthropologic and economic study in Burkina Faso to understand perceptions and behavior relative to meningitis and to determine the cost of illness from bacterial …

Author: Colombini A, Bationo F, Zongo S, et al.

Publication date: 2009

Costs of Meningitis Sequelae in Children in Dakar, Senegal

In economic evaluations of vaccines protecting against meningitis, treatment and productivity costs due to meningitis sequelae are rarely included in studies from low-income countries, mainly due to lack of data. This study, published in The …

Author: Griffiths UK, Dieye Y, Fleming J, Hajjeh R, Edmond K

Publication date: 2012

Critical Episodes in the Understanding and Control of Epidemic Meningococcal Meningitis

Epidemic meningococcal meningitis continues to be an important worldwide cause of morbidity and mortality, especially in developing countries. Throughout its history, a number of "critical episodes" have occurred that have enhanced understanding of …

Author: Artenstein AW, LaForce FM

Publication date: 2012

Definition and Characterization of Localised Meningitis Epidemics in Burkina Faso: A Longitudinal Retrospective Study

The epidemiology of meningococcal meningitis in the African meningitis belt is characterized by seasonality, localized epidemics, and epidemic waves. To facilitate research and surveillance, the authors of this article, published in BMC Infectious …

Author: Tall H, Hugonnet S, Donnen P, et al.

Publication date: 2012

Delivering MenAfriVac Using the Controlled Temperature Chain Approach

In November 2012, the first immunization campaign to use a controlled temperature chain (CTC) took place in northern Benin. This photo set by project Optimize contains images taken during the campaign, where more than 155,000 people were vaccinated …

Author: PATH, World Health Organization

Publication date: 2013

Development of a Group A Meningococcal Conjugate Vaccine, MenAfriVac™

Group A meningococcal disease has been an important public health problem in sub-Saharan Africa for over a century. From 2003 to 2009 a monovalent group A conjugate vaccine, MenAfriVac™, was developed through an innovative public/private …

Author: Frasch C, Preziosi M-P, LaForce FM

Publication date: 2012

Development of Vaccines Against Meningococcal Disease

This article, published in the Lancet, reviews the currently available vaccines against meningococcal disease, as well as research and development efforts toward the development of additional vaccines against the disease. ABSTRACT …

Author: Jódar L, Feavers IM, Salisbury D, Granoff DM

Publication date: 2002

Disease Control Priorities, Third Edition: Volume 2. Reproductive, Maternal, Newborn, and Child Health

This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age five. Of particular interest may be chapters 9, 10, and 19, which …

Author: Black RE, Laxminarayan R, Temmerman M, Walker N, eds.

Publication date: 2016

Disease Outbreak News

This web page provides frequently updated information about current disease outbreaks, as well as disease-specific archives of past alerts and links to related resources.

Author: World Health Organization

Diseases and the Vaccines that Prevent Them: For Parents of Preteens and Teens (7 Through 18 Years Old)

This series of fact sheets describes symptoms of infection as well as the benefits and risk of vaccination for several diseases, specifically for vaccines recommended for children aged 7 to 18 years. There are two types of fact sheets provided. …

Author: US Centers for Disease Control and Prevention

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

The authors of this article, published in The American Journal of Epidemiology, use data on immunization with serogroup C meningococcal conjugate vaccines in England and Wales to develop and apply a mathematical model that investigates the …

Author: Trotter CL, Gay NJ, Edmunds WJ

Publication date: 2005

An Economic Evaluation of the Controlled Temperature Chain Approach for Vaccine Logistics: Evidence From a Study Conducted During a Meningitis A Vaccine Campaign in Togo

This article, published in The Pan African Medical Journal, reports the results of a costing study conducted in Togo’s Central Region during a 2014 MenAfriVac® vaccine introduction campaign. The study evaluated the economic benefits of using an …

Author: Mvundura M, Lydon P, Gueye A, et al.

Publication date: 2017

Page 2 of 11